CIK 0001719714
- Non-accelerated filer
- Smaller reporting company
Mereo BioPharma Group plc
Sign in to watch- Ticker
- MREO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 3330237300
- Business address
- ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 88,657 shares at an average $4.30 ($381,423)
- 4 Open-market sale Chief Scientific Officer sold 16,149 shares at an average $4.30 ($69,477)
- 4 Open-market sale General Counsel sold 30,926 shares at an average $4.30 ($133,051)
- 4 Open-market sale Chief Financial Officer sold 28,286 shares at an average $4.30 ($121,693)
- 4 Open-market sale Hughes-Wilson Alexandra sold 148,110 shares at an average $4.30 ($637,203)
- 4 Exercise or conversion General Counsel acquired 65,600 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 60,000 shares (option exercise)
- 4 Exercise or conversion Chief Scientific Officer acquired 46,000 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 188,060 shares (option exercise)
- 4 Exercise or conversion Hughes-Wilson Alexandra acquired 208,333 shares (option exercise)
- 4 Open-market sale Director sold 105,244 shares at $4.43 ($466,210)
- 4 Open-market sale General Counsel sold 46,389 shares at an average $3.49 ($161,678)
- 4 Open-market sale Chief Scientific Officer sold 24,224 shares at an average $3.49 ($84,427)
- 4 Open-market sale Chief Financial Officer sold 42,429 shares at an average $3.49 ($147,876)
Page 2 of 4 · 80 filings